Search Results 411-420 of 17013 for pharmacogenetics

  1. A Study to Evaluate a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis - Mayo Clinic

    The purpose of this study is to characterize the risk of scoliosis progression based on local three-dimensional vertebral and pelvic measurements present on ...

  2. Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant - Mayo Clinic

    This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed multiple myeloma that are ...

  3. Medical Research & Education - Mayo Clinic News Network

    ROCHESTER, Minn. — For many people living with cancer, symptoms such as pain, anxiety or insomnia can quickly spiral into an emergency room visit. Such[...] ...

  4. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye - Mayo Clinic

    The purpose of this study is to compare the effectiveness of temozolomide to selumetinib for the treatment of patients who have melanoma of the eye that has ...

  5. Individualized Medicine for Cardiomyopathies - Zebrafish Genetics Lab: Xiaolei Xu - Mayo Clinic Research

    Mayo Clinic's Zebrafish Genetics Lab led by Xiaolei Xu, Ph.D., is discovering genes that help develop individualized medicine for idiopathic dilated ...

  6. News - Translational Cell Biology of Parkinson's Disease Laboratory - Mayo Clinic Research

    Read news highlighting gene studies in Parkinson's disease from Mayo Clinic's Translational Cell Biology of Parkinson's Disease Lab led by Wolfdieter ...

  7. Hodgkin Clinical Trials - Mayo Clinic Research

    This phase I trial studies the side effects and the best dose of everolimus when given together with brentuximab vedotin in treating patients with Hodgkin ...

  8. Myocardial Ischemia and Transfusion - Mayo Clinic

    Inclusion Criteria: 18 years of age or older; Either ST segment elevation myocardial infarction or Non ST segment elevation myocardial infarction consistent ...

  9. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

  10. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

    Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has ...